Previous Article | Next Article 
Journal of Bacteriology, June 1999, p. 3438-3444, Vol. 181, No. 11
0021-9193/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Mapping an Interface of SecY (PrlA) and SecE (PrlG)
by Using Synthetic Phenotypes and In Vivo Cross-Linking
Chris R.
Harris and
Thomas J.
Silhavy*
Department of Molecular Biology, Princeton
University, Princeton, New Jersey 08544
Received 15 January 1999/Accepted 6 April 1999
 |
ABSTRACT |
SecY and SecE are integral cytoplasmic membrane proteins that form
an essential part of the protein translocation machinery in
Escherichia coli. Sites of direct contact between these two proteins have been suggested by the allele-specific synthetic phenotypes exhibited by pairwise combinations of prlA and
prlG signal sequence suppressor mutations in these genes.
We have introduced cysteine residues within the first periplasmic loop
of SecY and the second periplasmic loop of SecE, at a specific pair of
positions identified by this genetic interaction. The expression
of the cysteine mutant pair results in a dominant lethal phenotype that requires the presence of DsbA, which catalyzes the formation of disulfide bonds. A reducible SecY-SecE complex is also observed, demonstrating that these amino acids must be sufficiently proximal to
form a disulfide bond. The use of cysteine-scanning mutagenesis enabled
a second contact site to be discovered. Together, these two points of
contact allow the modeling of a limited region of quaternary structure,
establishing the first characterized site of interaction between these
two proteins. This study proves that actual points of protein-protein
contact can be identified by using synthetic phenotypes.
 |
INTRODUCTION |
Gram-negative bacteria, such as
Escherichia coli, must transport proteins to several
different compartments, including the inner membrane, the outer
membrane, and the periplasmic space. Catalyzing these processes are a
number of cytoplasmic, peripheral, and integral membrane proteins,
including SecY (also known as PrlA; see below), SecE (PrlG), SecA
(PrlD), SecG (PrlH), SecB, SecD, and SecF (4, 11). SecA and
SecB recognize the hydrophobic N-terminal signal peptide and/or
portions of the mature sequence of the secretory protein. SecA
then interacts with integral membrane proteins, including
SecY and SecE, and this interaction triggers ATP-dependent
conformational changes in SecA (12, 13, 20, 27). ATP binding
leads to the periplasmic exposure of a portion of the secretory protein
N terminus, as well as the periplasmic exposure of SecA itself. SecA
subsequently hydrolyzes ATP and loses its exposure to the periplasm.
The translocation of the remaining portions of the secretory protein
can be catalyzed by repeated cycles of SecA insertion and deinsertion
or by the proton motive force, possibly through a channel comprised of
SecY, SecE, and SecG. The signal peptide is processed by a leader
peptidase during the translocation reaction.
The process of bacterial protein translocation has several features in
common with the translocation across the endoplasmic reticular membrane
of eukaryotes. For example, both processes employ cleavable signal
peptides, the sequences of which are virtually indistinguishable
(39). Bacterial proteins can be translocated by eukaryotes
(23) and vice versa (37). Moreover, several components of the translocation machinery are conserved in all of the
domains of life (33). The function and interactions of these
common proteins have thus drawn intense interest.
SecY and SecE are among the translocation proteins that have been
conserved across domains. Moreover, in E. coli, yeast,
and mammals, homologues of SecY and SecE can be found as part
of a protein complex (11, 34). It has been established
genetically and biochemically that SecY and SecE are in direct contact
(5-7, 14). Altogether there has been much attention
paid to the interaction between these extremely hydrophobic
proteins (1, 16, 19, 32, 41), including the recent
description of the complex with electron microscopy (25).
Unfortunately, many techniques for assessing protein structure are not
available for the analysis of membrane proteins like SecY and SecE.
Understanding the structure of this protein complex before and during
translocation likely will require new technologies.
In E. coli, certain alleles of secY and
secE, the prlA and prlG mutations,
respectively, suppress defective signal peptides enabling the
translocation of mutant secretory proteins (4). It was noted
from a previous study that one combination of these suppressor
prlA and prlG alleles results in a synthetic
phenotype (5). A synthetic phenotype is one created by
alleles of two different genes in combination, but not by either allele
by itself (17, 18). Often the phenotype is lethality: a cell
containing both mutant genes cannot grow. Synthetic phenotypes can
suggest a direct interaction between the products of the two genes.
A subsequent study of prlA and prlG allelic
combinations provided a glimpse into synthetic phenomena at a molecular
level (16). As membrane proteins, the residues of SecY and
SecE are found within three distinct compartments: the cytoplasm,
membrane, and periplasm. Of 88 different pairwise combinations of
prlA and prlG alleles examined, only five
produced synthetic phenotypes. Intriguingly, the positions of the
mutations were topologically juxtaposed. Three pairs of mutations
mapped to transmembrane helices, and two pairs of mutations mapped to
periplasmic loops. It was proposed that the loops and helices
containing these pairs of mutations interact directly.
A narrower hypothesis is that the sites of mutations identified in the
prlA and prlG study are positions of direct
contact between the two proteins. Here we test and verify this
hypothesis by exploiting the oxidizing environment of the periplasm to
produce a SecY-SecE complex that is specifically disulfide bonded
between these sites.
 |
MATERIALS AND METHODS |
Bacterial strains and plasmids.
E. coli strains
are ara+ derivatives of MC4100 (F
araD139
[argF-lac]U169 rpsL150 relA1
flbB5301 deoC1 ptsF25 rbsR). For protein analysis, an
ompT::Kn mutation was introduced into
these strains to prevent the proteolysis of SecY. Plasmid pAF26 has
been previously described (16). Plasmids pSecE and pSecY are
derivatives of pACYC177 into which wild-type copies of secE
and secY have been inserted, respectively. The
secE gene in pSecE is under the control of its own promoter.
The secY gene in pSecY is under control of the
trc promoter, which was obtained from pTrc99a (Pharmacia). Media were prepared as described previously (36).
Arabinose sensitivity assays.
The strain of interest was
grown to saturation in Luria-Bertani (LB) broth, washed three times in
10 mM MgSO4-5 mM CaCl, and then mixed with 3 ml of F-top
agar at 47°C. This suspension was then poured onto M63 minimal agar
containing glycerol and ampicillin. After the top agar had solidified,
a small disc of filter paper was placed in the middle of the dish, and
15 µl of 20% arabinose was added to the disc. The plates were
incubated at 37°C for 16 h, and then zones of growth inhibition
were measured.
Site-directed mutagenesis.
Single point mutations were
generated in the secE gene encoded by plasmid pAF26
(16) by using the unique site elimination method
(9).
Nonreducing PAGE.
E. coli strains were grown
to saturation in LB broth and then subcultured into M9 media containing
glycerol and ampicillin supplemented with 1% LB broth. After
5 h, arabinose was added to a concentration of 0.2%, and cultures
were grown for 90 min. Iodoacetamide was added to a concentration
of 25 mM (10), and then trichloroacetic acid (TCA) was added
to a concentration of 5%. Protein pellets were washed in 5% TCA,
washed in acetone, and then resuspended in 1% sodium dodecyl sulfate
(SDS)-50 mM Tris (pH 7.5)-1 mM EDTA-50 mM iodoacetamide. Samples
were normalized for cell number and then mixed with an
SDS-polyacrylamide gel electrophoresis (PAGE) loading buffer containing
either dithiothreitol (DTT) or iodoacetamide. Samples were heated to
55°C for 30 min prior to electrophoresis. Proteins were
electrophoresed in a gel consisting of SDS-12.5% polyacrylamide by
using a Bio-Rad Protean II miniapparatus. Antibodies raised against
SecE,
-lactamase, murein lipoprotein, or the N terminus
of SecY were used to visualize proteins. Chemiluminescence was
performed by using solutions supplied by Amersham Corp.
Incorporation of [35S]methionine into polypeptide.
E. coli strains were grown to saturation in LB broth
and then subcultured into M9 media containing glycerol and ampicillin supplemented with 1% LB broth. After 2 h, arabinose was added to
a concentration of 0.2%, and cultures were further grown for between
10 and 180 min. A short pulse of [35S]methionine was
applied and then quenched by the addition of TCA to a concentration of
5%. Protein pellets were washed twice in 5% TCA and once in acetone
and then were resuspended in 1% SDS-50 mM Tris (pH 7.5)-1 mM EDTA.
Samples were normalized for cell number, and then the
[35S]methionine incorporated into acid-precipitable
protein was measured with a Beckman LS-1701 liquid scintillation counter.
Flow cytometry.
Cultures of the prlA3
secE(S120C) strain, as well as isogenic control strains, were
exposed to arabinose for 1 or 4 h, pelleted by
microcentrifugation, and then washed twice in 10 mM
MgSO4-5 mM CaCl2. Cells were mixed with SYTOX
Green or DIBAC4 as previously described (24,
35). A permeabilized control was also generated, by resuspending
the cells in 70% ethanol for 5 min prior to washing in 10 mM
MgSO4-5 mM CaCl2. Flow cytometry was performed
by using a FACScan instrument (Becton Dickinson). Fluorescence was
excited at 488 nm, and then emission measurements were collected at 530 nm (SYTOX Green) or 516 nm (DIBAC4).
Measurement of CFU.
E. coli strains were grown to
saturation in LB broth and then subcultured into M9 media containing
glycerol and ampicillin supplemented with 1% LB broth. After 2 h,
arabinose was added to a concentration of 0.2%, and the optical
density at 600 nm was measured. An aliquot of cells was removed,
diluted 105-fold, and plated directly onto LB agar
containing ampicillin. Platings were repeated every 30 min for 4 h. Plates were incubated at 37°C overnight, and colonies were counted.
 |
RESULTS |
A synthetic phenotype that requires the function of DsbA.
prlG3, which causes a substitution of phenylalanine for
serine at position 120 (S120F) of SecE, was previously shown to be synthetically lethal with prlA3, which causes a substitution
of cysteine for phenylalanine at position 67 (F67C) of SecY (16, 28). Both residues localize to the periplasm, an oxidizing
environment in which disulfide bonds can form. We reasoned that if
these two residues are normally points of direct contact between the
two proteins, then replacing serine-120 of SecE with cysteine might enable disulfide bonding to the cysteine substitution in PrlA3.
The cysteine mutant of SecE, secE(S120C), was created on
a plasmid from which the expression of the gene could be controlled conditionally. The gene is controlled by a promoter, PBAD,
such that expression is only induced in the presence of the sugar
arabinose. This plasmid was used to transform a strain of E. coli in which prlA3 and secE+
were present on the chromosome.
While it is possible to transform the plasmid encoding
secE(S120C) into the
prlA3 strain under
noninducing conditions, the
addition of arabinose results in a severe
growth defect. This
is best illustrated on a petri dish as a zone of
arrested growth
surrounding a filter paper disc containing arabinose
(Table
1).
The
secE(S120C)
gene alone is not responsible for this zone of
arrested growth, because
a
secY+ strain containing this plasmid does not
display the same phenotype
(Table
1); nor does the overproduction of
secE+ in the
prlA3 strain result in a
growth defect. Since only the
combination of
secE(S120C)
expression in the
prlA3 background
results in a growth
defect, this defect is a synthetic phenotype.
Given that other mutations at these two positions in SecE and SecY have
previously been shown to yield synthetic combinations
(
16),
we were not surprised by this growth defect. However,
there is a novel
and very striking phenotype specific to the strain
containing both
cysteine mutants. As discussed above, if the two
cysteine residues are
closely apposed within the native SecY-SecE
protein complex, they might
form a disulfide bond when both proteins
are expressed, and the
formation of this disulfide bond might
account for the dramatic growth
defect. This reasoning predicts
that the growth defect would be
suppressed by knocking out the
gene encoding DsbA, the enzyme
responsible for catalyzing disulfide
bond formation in the periplasm of
E. coli (
3). This turns
out to be the case.
In the
prlA3 dsbA::
kan strain
background,
the expression of
secE(S120C) does not
confer a growth defect
(Table
1). Moreover, the presence of cystine, an
oxidizing agent
that partially suppresses the loss of
dsbA
(
2), also partially
inhibits the growth of the
secE(S120C) prlA3 dsbA::
kan strain
(Table
1).
As a negative control to show that the
dsbA gene disruption
has no effect upon synthetic phenotypes in general, this null
allele
was introduced into a
prlG8 prlA726 strain. These alleles
combine to give a strong synthetic phenotype (
16). However,
neither mutation encodes a cysteine, and the
dsbA gene
disruption
has no effect upon the growth defect of either
the
prlG3 prlA3 strain or the
prlG8 prlA726
strain (data not shown). Thus, the
growth problems of the
secE(S120C) prlA3 strain depend upon disulfide
bond
formation.
Altogether the results presented in this section indicate that
positions 120 of SecE and 67 of SecY are close enough to permit
disulfide bond formation between them. Moreover they suggest that
this
cross-linked SecY-SecE complex causes a growth
defect.
A high degree of allele specificity.
Data in the previous
section indicate that positions 120 of SecE and 67 of SecY are linked
covalently when replaced by cysteine residues. This suggests that the
amino acids are extremely proximal within the protein complex. However,
it could also represent a more nonspecific association. For
example, the two amino acids could be within domains sufficiently
flexible to occasionally slide close to one another. DsbA would then
act to fix the interaction covalently. We sought to rule out this
possibility by examining position dependency. If the domains are
flexible, then most amino acid substitutions in the nearby region
should result in cross-links. On the other hand, if the domain
interaction is relatively static, we would expect that cross-linking
would be specific to the original pair of cysteine mutants.
The synthetic phenotype created by the
secE(S120C)-prlA3
gene pair turns out to be highly position specific. The original
plasmid carrying
secE(S120C) was tested to see if it can
confer
a growth defect on a strain expressing either
prlA205, which causes
a substitution of cysteine for glycine
at position 69, or
prlA300,
which causes a substitution of
cysteine for phenylalanine at position
64 of SecY (
28). Even
though the mutations are tightly linked
to the F67C substitution
in
prlA3,
secE(S120C) expression does
not affect the growth of these strains (Table
1).
Four more alleles of
secE, also plasmid localized and under
arabinose control, were created in which cysteines replace amino
acids
118, 121, 122, and 124. The results of expressing each new
mutant in
the wild-type,
prlA3,
prlA205, and
prlA300 backgrounds
are shown in Table
2. As measured by the aforementioned
filter
disc assay, none of the new alleles confers arabinose
sensitivity
upon a wild-type strain, and nearly all allelic
combinations are
benign. One novel synthetic combination was
discovered:
secE(G124C) expression in a
prlA300 strain leads to a growth defect.
prlA300 causes a substitution of cysteine for phenylalanine at position
64 of
SecY. As was previously the case, knocking out
dsbA
overcomes
the growth defect of the
prlA300 secE(G124C)
strain. It therefore
appears that positions 124 of SecE and 64 of SecY,
like positions
120 of SecE and 67 of SecY, are sufficiently proximal to
form
a disulfide bond. Moreover these results further strengthen the
causal relationship between cross-linked SecY and SecE and the
observed
growth defect.
A reducible SecY-SecE complex.
If position 67 of SecY and
position 120 of SecE are points of direct contact, it should be
possible to detect a reducible SecY-SecE complex when both of these
residues are replaced by cysteine. Western blots presented in Fig.
1 show the disulfide-bonded complex
formed by PrlA3 and SecE(S120C). When anti-SecY sera are used as a
probe, a novel 45-kDa band appears under oxidizing conditions only in
extracts from the strain expressing both cysteine mutant proteins (Fig.
1A). A band of precisely the same size, 45 kDa, also appears when
anti-SecE sera are used as a probe (Fig. 1B). Upon reduction with DTT,
the 45-kDa band disappears, demonstrating that the complex is disulfide
bonded (Fig. 1A, lane 4). Thus, the 45-kDa band contains both SecY and
SecE, is present only in strains producing both PrlA3 and
SecE(120C), and disappears when DTT is added. Such data could be
obtained only if position 67 of SecY and position 120 of SecE were
sufficiently close in the SecY-SecE complex to allow disulfide bond
formation.

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 1.
Disulfide bonding of PrlA3 and SecE(S120C). Alleles
are shown, including the wild type (+), the prlA3 gene,
which codes for an F67C point mutation (A3), and
secE(S120C) (S120C). (A) Total protein from
strains expressing the secE and secY alleles
indicated was TCA precipitated in the presence of iodoacetamide and
then electrophoresed in the oxidized state (lanes 1 to 3) or reduced
with DTT (lane 4). SecY antisera were used to visualize SecY and SecY
protein complexes. (B) Total protein was precipitated in the presence
of iodoacetamide and then electrophoresed in the oxidized state. SecE
antisera were used to visualize SecE and SecE protein complexes.
|
|
In strains producing both PrlA3 and SecE(120C) an additional 25-kDa
band that disappears upon reduction is recognized by the
SecE antibody
(Fig.
1B). This band is also recognized by the SecY
antisera, although
the band intensity is much weaker (data not
shown). Unlike the SecE
antisera, which were generated against
whole protein, the SecY antisera
recognize only the N-terminal
20 amino acids of the protein. We suspect
that the 25-kDa band
represents a degradation product of the 45-kDa
SecE(S120C)-PrlA3
covalent complex and that part of the SecY N
terminus is removed
by the proteolysis event. This explanation would
account for both
the smaller size and the poor recognition of the
25-kDa band by
the SecY
antibody.
One band, of approximately 30 kDa, is detected only by the SecE
antibody (Fig.
1B). This band disappears upon reduction (data
not
shown), but it is present in all of the strains producing
SecE(120C), not just the
secE(S120C) prlA3 strain.
Thus, it cannot
account for the toxicity of the
latter.
We have searched for a specific disulfide-bonded complex in strains
expressing the synthetic lethal pair
prlA300 and
secE(G124C).
Unfortunately, for this particular
combination of alleles, the
results obtained with Western blots are not
conclusive. In any
strain expressing
prlA300,
including the
secE+ background, there is a
band(s) recognized by the SecY antibody
in the 45-kDa range (data
not shown). Thus, we cannot be sure
that any of the bands that we see
in the double mutant with SecE
antisera really contain
PrlA300.
Strains that do not demonstrate a synthetic phenotype have been
examined, and we were unable to see a covalent SecY-SecE complex
in any
of them. For example, when
secE(L118C) or
secE(I122C) is
expressed in the
prlA3
background, a 45-kDa band cannot be seen
under nonreducing
conditions when probed with either SecY or SecE
antiserum (data
not shown). Thus, the side chains of residues
118 and 122 of SecE and
67 of SecY do not appear to be within
disulfide-bonding
distance.
Biochemical data presented in this section verify an important
prediction of the genetic results presented above: SecE(S120C)
and
PrlA3 can form a disulfide-bonded complex. Although we have
looked, we
have not found a reducible SecY-SecE complex in strains
that do not
exhibit a synthetic phenotype. This latter result
is consistent with
the view that the cross-linked complex causes
the observed growth
defects.
Expression of secE(S120C) is toxic in
prlA3 strains.
It is not immediately obvious why
cross-linking SecY and SecE at a point of normal contact would cause a
growth defect. In an effort to address this issue and in the hope of
learning more about the functional role(s) of SecY and SecE, we have
examined some of the changes in cellular physiology caused by the
expression of secE(S120C) in a prlA3 strain.
First, we tested whether
secE(S120C) expression in a
prlA3 strain causes cell death or simply results in a growth
arrest.
As shown in Fig.
2, there is a
strong effect on cell viability
2 h following
secE(S120C) induction. By 3.5 h postinduction, 99%
of cells have lost the ability to form colonies on permissive
media.
Thus, SecE(S120C) is toxic in
prlA3 strains; after a
period
of time or at some critical concentration it causes cell death.

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 2.
Toxicity of secE(S120C) expression in
prlA3 strain. At 0 min, arabinose was added to
secE(S120C) prlA3 (squares), secE(S120C)
secY+ (diamonds), and secE+
prlA3 (circles) strains. Aliquots were removed at various times
postinduction, and CFU were measured. Also shown are CFU of the
secE(S120C) prlA3 strain culture in the absence of
arabinose (triangles).
|
|
We considered the possibility that a covalent linkage would inactivate
SecY and SecE, thus depleting the cells of these essential
proteins.
Several lines of evidence argue against this simple
model. First,
strains depleted of most Sec proteins, including
SecY and SecE,
become cold sensitive (
31), whereas the arabinose
sensitivity of the
prlA3 secE(S120C) strain is lessened
rather
than increased by incubation at lower temperatures (data not
shown).
More convincing evidence is provided by diploid analysis. We
call
attention to the last strain listed in Table
1. This strain
contains
secE(S120C) and
prlA3, but it also
contains
secE+ on the chromosome and
secY+ on a second, compatible plasmid. It is
difficult to imagine how
cross-linking could deplete this diploid
strain of functional
SecY and SecE, yet toxicity is still observed. We
conclude that
toxicity is dominant, and this suggests that cell death
is precipitated
by some acquired novel
function.
One altered function that the cross-linked complex might acquire would
be the ability to titrate some other Sec protein or
another secretion
factor such as a component of the prokaryotic
signal recognition
particle (pSRP). To test this possibility assays
were performed to
determine if the expression of
secE(S120C) in
prlA3 strains leads to a block in translocation. The failure
to
cleave signal peptides, resulting in the accumulation of the
higher-molecular-weight
precursor species, can be used to indicate
translocation defects.
When

-lactamase
translocation is analyzed in this way, the amount
of

-lactamase precursor clearly increases (Fig.
3). However,

-lactamase
translocation is known to be sensitive to changes
in cellular
physiology other than a defect in the secretion machinery,
such
as lowered levels of GroEL and GroES (
21,
30). Indeed,
under identical conditions the translocation of other proteins,
including murein lipoprotein (Fig.
3), OmpF, and PhoA, is
unaffected
(data not shown). Moreover, using the assay of
Ulbrandt et al.
(
38), we find that the membrane
insertion of

-ketoglutarate
permease, which was shown to be
strongly dependent upon pSRP,
is unaffected as well (data not shown).
Thus, we can find no evidence
for a secretion defect severe
enough to kill cells.

View larger version (68K):
[in this window]
[in a new window]
|
FIG. 3.
Protein translocation in prlA3
secE(S120C) cells. (A) prlA3 secE(S120C) cells
were induced for secE(S120C) expression with arabinose
(lanes 1 and 2) for 2 h or were left uninduced (lanes 3 and 4).
Cultures were pulse labeled for 30 s with
[35S]methionine and chased for 30 s (lanes 1 and 3)
or 4 min (lanes 2 and 4), and then the protein was TCA precipitated.
-Lactamase was collected by immunoprecipitation and separated by
SDS-PAGE. The positions of precursor (p) and mature (m)
-lactamase are shown. (B) prlA3
secE(S120C) cells were induced for secE(S120C)
expression with arabinose (lanes 3 and 4) for 2 h or were left
uninduced (lanes 1 and 2). Cultures were pulse labeled for 30 s
with [35S]methionine and chased for 30 s (lanes 1 and 3) or 4 min (lanes 2 and 4), and then the protein was TCA
precipitated. Lipoprotein was collected by immunoprecipitation and
separated by SDS-PAGE. Only mature lipoprotein was present.
The lipoprotein precursor could not be detected.
|
|
As noted in the introduction, SecY and SecE are part of a large complex
that is thought to form a protein-conducting channel
in the inner
membrane (
25,
34). A covalent bond between these
two
proteins might lock the complex in an open or partially open
conformation, which would result in the depolarization of the
membrane.
Since this would be an acquired function, it would explain
the
dominance observed in the diploid
strain.
We tested for permeability changes as follows:
prlA3 cells
that were induced for
secE(S120C) expression for as long
as 4 h
were exposed to DIBAC
4, a compound that
fluoresces in the presence
of a membrane potential, and SYTOX
Green, a compound that fluoresces
upon membrane rupture. Using
flow cytometry as previously described
(
24,
35), we could
find no decrease in DIBAC
4 fluorescence
or any increase in
SYTOX Green fluorescence (data not shown).
Therefore, there is no
indication of either membrane depolarization
or rupture. The channel
does not appear to be locked
open.
While performing the translocation assays described above, we
discovered a significant but unexpected defect in the
prlA3 secE(S120C) strain. As shown in Fig.
4, the levels of labeled
protein begin to
decrease shortly after the induction of the
secE(S120C) gene. By 90 min postinduction total protein labeling is reduced
by
80%.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 4.
PrlA3 and SecE(S120C) cross-linking inhibits the
incorporation of the radioactive methionine into polypeptide. At 0 min,
arabinose was added to the strains with the following genotypes:
secE(S120C) prlA3 (squares), secE(S120C)
secY+ (diamonds), and secE+
prlA3 (circles). At various time points samples were removed, and
the ability of cells to incorporate [35S]methionine into
polypeptide was measured by pulse labeling followed by TCA
precipitation and radioactivity measurement as described in Materials
and Methods.
|
|
We do not understand how the cross-linking of SecE(S120C) to PrlA3
can result in the decreased incorporation of methionine
into protein.
Because the membranes remain polarized (see above),
the defect is
probably not due to amino acid uptake. Rather it
is likely to
be related to transcription, translation, or protein
stability. We have
not investigated this defect further, because
we are not certain
whether this change in cellular physiology
is the primary cause of
death. Indeed, for reasons described in
the following section, we
suspect that the cytotoxicity is the
cumulative effect of a complex
cascade of cellular
defects.
 |
DISCUSSION |
In a previous study, it was demonstrated that allele-specific
combinations of prlA and prlG give rise to
synthetic phenotypes (16). Strikingly, the pairs of
mutations that produce these synthetic phenotypes always mapped to the
same cellular compartment; either both resided within the periplasm or
both resided within the membrane. This combination of allele
specificity and topological coincidence led to the proposal that the
domains containing these residues interact directly. In particular,
since the synthetic defect in all cases was recessive to
secY+ or secE+ provided
in trans and since recessive behavior implies a loss of
function, it was concluded that the prl mutations in
question disrupt a normal, functionally important interaction between
SecY and SecE.
Here we have directly tested the hypothesis that the synthetic pair,
prlA3 and prlG3, define a site of contact between
SecY and SecE. Both of these mutations alter amino acid residues
in periplasmic domains. If residues 67 of SecY and 120 of SecE are in
close contact, then the oxidizing environment of this cellular compartment should allow disulfide bond formation if both residues are
replaced by cysteine. Genetic and biochemical experiments demonstrate
disulfide bond formation between PrlA3 and SecE(S120C). This proves
that actual points of protein-protein contact can be identified by
using allele-specific synthetic phenotypes.
The genetic data demonstrating disulfide bond formation between PrlA3
and SecE(S120C) are compelling. The synthetic lethality observed
with these cysteine substitutions is dominant to both secY+ and secE+ provided
in trans, and this allows us to distinguish it from the
recessive synthetic lethality observed previously by Flower et al.
(16) with other amino acid substitutions at these positions. Dominant synthetic lethality requires cysteines at position 67 of SecY
and 120 of SecE. No other amino acid at either position will do.
This is a case of extreme allele specificity. Dominant synthetic
lethality is also unique in that it requires DsbA, the periplasmic
enzyme that catalyzes disulfide bond formation. In the absence of this
enzyme, no synthetic phenotypes are detectable with the cysteine
substitutions unless an oxidizing agent is added to the growth media.
Alternative models for dominant synthetic lethality that account for
all of these facts invariably invoke a hypothetical molecule(s), and
these complex scenarios fail to adequately explain the recessive
synthetic lethality observed by Flower et al. (16). We
conclude that dominant synthetic lethality is due to disulfide-bonded
PrlA3-SecE(S120C).
Biochemical support for a disulfide-bonded
PrlA3-SecE(S120C) is provided by Western blot analysis.
SDS-PAGE with nonreduced samples reveals a new band of 45 kDa that
is recognized by both SecY and SecE antibodies. This band
disappears when DTT is added, and it is specific to strains that
synthesize PrlA3 and SecE(S120C). These results provide direct
evidence that residues 67 of SecY and 120 of SecE are sufficiently
close to allow disulfide bond formation.
The amount of cross-linked PrlA3-SecE(S120C) is relatively small
compared with the total amount of SecE present (Fig. 1B), and this
merits further comment. Since secE is an essential gene and
the gene pair secE(S120C)-prlA3 confers a dominant toxic
phenotype, maintaining the prlA3 secE(S120C) strain
requires the repression of secE(S120C) and the presence
of the secE+ gene. Prior to the induction of
secE(S120C), all of the PrlA3 is thus partnered with
wild-type SecE, and this complex will not be disulfide bonded. Upon
induction, most of the SecE protein is SecE(S120C). However, since
PrlA3 is not co-overexpressed, most of the SecE(S120C) is likely to
lack a PrlA3 partner and therefore cannot yield a cross-linked complex.
Moreover, there is evidence that preformed SecYE complexes are stable
and do not mix with newly synthesized molecules of either protein
(19). Thus overexpressing SecE(S120C) would not be
expected to contribute to disulfide bonding within existing
PrlA3-SecE+ complexes. It may be possible to optimize
conditions for the formation of the cross-linked product in order to
study its properties in vitro, such as by co-overexpressing PrlA3 with
SecE(S120C). However, there are expression problems in this strain
(Fig. 4), and we also see a 25-kDa band that is likely a degradation
product (Fig. 1B). Both the expression defect and degradation may
contribute in a negative fashion to the overall yield.
A second issue raised by the Western blots is the presence of
cross-linked species in addition to the PrlA3-SecE(S120C) complex. For instance, there is a prominent band at 30 kDa in Fig. 1B. Either
this represents a SecE homodimer or else there is a high degree of
cross-linking between SecE(S120C) and another cysteine-containing protein of the periplasm. Indeed, upon further exposure of the gels in
Fig. 1, we can see several other discrete cross-linked products (data
not shown). Apparently cysteine residues in the periplasm are quite
active chemically. Whatever the composition of these disulfide-bonded
complexes, they seem to have no effect on cell growth and
viability, even when prlA3, prlA205, or
prlA300 is the sole copy of the secY gene in the
cell. However, these additional bands can interfere with biochemical
analysis, as was seen with the prlA300 strain.
The synthetic lethality observed with the SecY and SecE cysteine
substitution mutations is exquisitely position dependent. In total 15 different pairwise combinations of SecY and SecE cysteine substitution
mutations were tested, and all of these substitutions were confined to
tightly clustered regions: three in SecY at codons 64, 67, and 69 and
five in SecE at codons 118, 120, 121, 122, and 124. DsbA-dependent,
dominant synthetic lethality was only observed in 2 of the 15:
prlA3 secE(S120C) and prlA300
secE(G124C). In all of the other cases, no synthetic
phenotypes were observed. We conclude that these two points of contact
define small interactive domains in both SecY and SecE.
From these two points of contact, a model for the local quaternary
structure may be gleaned. Model building indicates that arranging these
two periplasmic loops as antiparallel
-helices places both pairs of
contacting side chains, SecY-64-SecE-124 and SecY-67-SecE-120, within
bonding distance (Fig. 5). Model building
rules out an antiparallel
-conformation, since both points of
contact cannot be brought together. Secondary structure algorithms also
suggest that this region of SecY is helical, although no prediction is
made with respect to the region of SecE. The model shown in Fig. 5
is also supported by the benign phenotypes of most of the cysteine
mutant pairs, since in this model the relevant side chains are not
within covalent-bonding distance. This approach of scanning a local
region with cysteine point mutants and looking for disulfide bonding
has previously revealed interactive faces within domains of a single
protein or within proteins that form homomeric complexes (15, 22,
26, 29, 40). We show that the approach can also be applied to
heteromeric protein complexes.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 5.
Molecular modeling of the regions subjected to cysteine
scanning mutagenesis. The second periplasmic loop of the SecE protein
and the first periplasmic loop of the SecY protein are depicted as
antiparallel -helices. The positions of the amino acids subjected to
cysteine scanning are shown as numbers within circles. We have linked
the amino acids at points sufficiently proximal to form disulfide bonds
when replaced by cysteines.
|
|
While this study identifies specific contact sites between SecY and
SecE, it is by no means an exhaustive search. Other interactions between these proteins must exist. Preliminary data indicate that periplasmic loop 1 of SecY, which includes the contact points shown in
Fig. 5, can be deleted without eliminating SecY function (27a). Thus, assuming that the SecY-SecE
interaction is essential, this region cannot be the only domain in
which the two proteins are in contact. There are data suggesting that
SecY and SecE have a cytoplasmic contact, with one of the sites on
cytoplasmic loop 5 of SecY and another site (which is not necessarily
the partner of the first) on cytoplasmic loop 2 of SecE (1,
33). At a finer level, other synthetic phenotypes suggest
interactions between specific amino acids within transmembrane helices
7 and 10 of SecY and transmembrane helix 3 of SecE (16).
As noted in Results, it is not immediately obvious why cross-linking
SecY and SecE at a point of normal contact would cause cell death.
Since the synthetic lethality observed with these cysteine
substitutions is dominant to both secY+ and
secE+ provided in trans and since
protein secretion is largely unperturbed in dying cells, it is clear
that death is not caused by a lack of functional SecY or SecE.
Rather, the cross-linked complex must actively kill cells.
It appears that the covalent linkage between PrlA3 and SecE(S120C)
activates a novel function for the SecYE protein complex. Exactly what
this function might be is a mystery. Ordinarily, we might expect to
find an answer within the physiology of the afflicted cells. However,
it appears that the cause of death in these strains is quite
complicated. We have managed to rule out the more obvious possibilities
that would be consistent with a dominant phenotype: both membrane
integrity and potential remain intact; the cold resistance of the
cytotoxicity and the lack of translocation defects for most of the
proteins tested argue against the titration of other Sec proteins; and
the lack of an effect on the membrane insertion of
-ketoglutarate
permease indicates that pSRP is not limiting. Of the changes in
physiology that do occur, the most striking is a reduced ability to
label newly synthesized proteins. However, this defect is
apparent within 1 h of induction of the secE(S120C)
gene, whereas most cell death occurs much later. Since hours
elapse between this change in cellular physiology and the onset of cell
death, we cannot be certain if it is the direct cause. We suspect that
SecY-SecE cross-linking triggers a complex series of events that
progressively weaken the cell to the point of death.
An understanding of the mechanism of toxicity would be germane, were we
attempting to analyze the functional role of SecY and SecE. Here
we probe the structure of the SecY-SecE complex, not its function, and
our conclusions about structure will not change regardless of the
mechanism by which the cross-linked complex kills the cell. It is
important to note that genetic analysis can provide very specific
information even when the phenotypes in question are complex and poorly
understood. For example Crick et al. (8) used genetics to
provide key insights into the nature of the genetic code and gene
structure long before the phenotypes of T4 rII mutants were understood.
Our results demonstrate that allele-specific synthetic phenotypes can
identify points of direct contact between interacting proteins. They
also show that DsbA can catalyze the formation of nonnative disulfide
bonds among the subunits of multimeric protein complexes. We
believe that these approaches will prove to be generally useful.
 |
ACKNOWLEDGMENTS |
We are grateful to Robert Osborne and Ann Flower, who contributed
strains and plasmids and conducted seminal experiments leading to this
study, to Masayori Inouye and Koreaki Ito for the generous gift
of antisera, to Harris Bernstein for the
-ketoglutarate permease plasmids, to Andrew Beavis, who helped with flow
cytometry, and to Richard Ebright and Austin Newton for helpful suggestions.
This work was supported by NIGMS grant GM34821 to T.J.S.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Princeton
University, Department of Molecular Biology, 310 Lewis Thomas
Laboratory, Washington Rd., Princeton, NJ 08544. Phone: (617) 258-5899. Fax: (617) 258-2957. E-mail:
tsilhavy{at}molbio.princeton.edu.
 |
REFERENCES |
| 1.
|
Baba, T.,
T. Taura,
T. Shimoike,
Y. Akiyama,
T. Yoshihisa, and K. Ito.
1994.
A cytoplasmic domain is important for the formation of a SecY-SecE translocator complex.
Proc. Natl. Acad. Sci. USA
91:4539-4543[Abstract/Free Full Text].
|
| 2.
|
Bardwell, J. C.,
J. O. Lee,
G. Jander,
N. Martin,
D. Belin, and J. Beckwith.
1993.
A pathway for disulfide bond formation in vivo.
Proc. Natl. Acad. Sci. USA
90:1038-1042[Abstract/Free Full Text].
|
| 3.
|
Bardwell, J. C. A.,
K. McGovern, and J. Beckwith.
1991.
Identification of a protein required for disulfide bond formation in vivo.
Cell
67:581-589[Medline].
|
| 4.
|
Bieker, K. L.,
G. J. Phillips, and T. J. Silhavy.
1990.
The sec and prl genes of Escherichia coli.
J. Bioenerg. Biomembr.
22:291-310[Medline].
|
| 5.
|
Bieker, K. L., and T. J. Silhavy.
1990.
PrlA (SecY) and PrlG (SecE) interact directly and function sequentially during protein translocation in E. coli.
Cell
61:833-842[Medline].
|
| 6.
|
Bieker-Brady, K., and T. J. Silhavy.
1992.
Suppressor analysis suggests a multistep, cyclic mechanism for protein secretion in Escherichia coli.
EMBO J.
11:3165-3174[Medline].
|
| 7.
|
Brundage, L.,
J. P. Hendrick,
E. Schiebel,
A. J. M. Driessen, and W. Wickner.
1990.
The purified E. coli integral membrane protein SecY/E is sufficient for reconstitution of SecA-dependent precursor protein translocation.
Cell
62:649-657[Medline].
|
| 8.
|
Crick, F. H. C.,
L. Barnett,
S. Brenner, and R. J. Watts-Tobin.
1961.
General nature of the genetic code for proteins.
Nature
192:1227-1232[Medline].
|
| 9.
|
Deng, W. P., and J. A. Nickoloff.
1992.
Site-directed mutagenesis of virtually any plasmid by eliminating a unique site.
Anal. Biochem.
200:81-88[Medline].
|
| 10.
|
Derman, A. I.,
W. A. Prinz,
D. Belin, and J. Beckwith.
1993.
Mutations that allow disulfide bond formation in the cytoplasm of Escherichia coli.
Science
262:1744-1747[Abstract/Free Full Text].
|
| 11.
|
Duong, F.,
J. Eichler,
A. Price,
M. R. Leonard, and W. Wickner.
1997.
Biogenesis of the Gram-negative bacterial envelope.
Cell
91:567-573[Medline].
|
| 12.
|
Economou, A.
1998.
Bacterial preprotein translocase: mechanism and conformational dynamics of a processive enzyme.
Mol. Microbiol.
27:511-518[Medline].
|
| 13.
|
Economou, A., and W. Wickner.
1994.
SecA promotes preprotein translocation by undergoing ATP-driven cycles of membrane insertion and deinsertion.
Cell
78:835-843[Medline].
|
| 14.
|
Esnault, Y.,
D. Feldheim,
M.-O. Blondel,
R. Schekman, and F. Kepes.
1994.
SSS1 encodes a stabilizing component of the Sec61 subcomplex of the yeast protein translocation apparatus.
J. Biol. Chem.
269:27478-27485[Abstract/Free Full Text].
|
| 15.
|
Falke, J. J., and D. E. Koshland, Jr.
1987.
Global flexibility in a sensory receptor: a site-directed cross-linking approach.
Science
237:1596-1600[Abstract/Free Full Text].
|
| 16.
|
Flower, A. M.,
R. S. Osborne, and T. J. Silhavy.
1995.
The allele-specific lethality of prlA-prlG double mutants predicts interactive domains of SecY and SecE.
EMBO J.
14:884-893[Medline].
|
| 17.
|
Guarente, L.
1993.
Synthetic enhancement in gene interaction: a genetic tool come of age.
Trends Genet.
9:362-366[Medline].
|
| 18.
|
Huffaker, T. C.,
M. H. Hoyt, and D. Botstein.
1987.
Genetic analysis of the yeast cytoskeleton.
Annu. Rev. Genet.
21:259-284[Medline].
|
| 19.
|
Joly, J. C.,
M. R. Leonard, and W. Wickner.
1994.
Subunit dynamics in Escherichia coli preprotein translocase.
Proc. Natl. Acad. Sci. USA
91:4703-4707[Abstract/Free Full Text].
|
| 20.
|
Kim, Y. J.,
T. Rajapandi, and D. Oliver.
1994.
SecA protein is exposed to the periplasmic surface of the E. coli inner membrane in its active state.
Cell
78:845-853[Medline].
|
| 21.
|
Kusukawa, N.,
T. Yura,
C. Ueguchi,
Y. Akiyama, and K. Ito.
1989.
Effects of mutations in heat-shock genes groES and groEL on protein export in Escherichia coli.
EMBO J.
8:3517-3521[Medline].
|
| 22.
|
Lee, G. F.,
G. G. Burrows,
M. R. Lebert,
D. P. Dutton, and G. L. Hazelbauer.
1994.
Deducing the organization of a transmembrane domain by disulfide cross-linking. The bacterial chemoreceptor Trg.
J. Biol. Chem.
269:29920-29927[Abstract/Free Full Text].
|
| 23.
|
Lingappa, V. R.,
J. Chaidez,
C. S. Yost, and J. Hedgpeth.
1984.
Determinants for protein localization: beta-lactamase signal sequence directs globin across microsomal membranes.
Proc. Natl. Acad. Sci. USA
81:456-460[Abstract/Free Full Text].
|
| 24.
|
Mason, D. J.,
E. G. M. Power,
H. Talsania,
I. Phillips, and V. A. Gant.
1995.
Antimicrobial action of ciprofloxacin.
Antimicrob. Agents Chemother.
39:2752-2758[Abstract].
|
| 25.
|
Meyer, T. H.,
J. F. Menetret,
R. Breitling,
K. R. Miller,
C. W. Akey, and T. A. Rapoport.
1999.
The bacterial SecY/E translocation complex forms channel-like structures similar to those of the eukaryotic Sec61p complex.
J. Mol. Biol.
285:1789-1800[Medline].
|
| 26.
|
Milligan, D. L., and D. E. Koshland, Jr.
1992.
Site-directed cross-linking: establishing the dimeric structure of the aspartate receptor of bacterial chemotaxis.
J. Biol. Chem.
263:6268-6275[Abstract/Free Full Text].
|
| 27.
|
Nishiyama, K.,
T. Suzuki, and H. Tokuda.
1996.
Inversion of the membrane topology of SecG coupled with SecA-dependent preprotein translocation.
Cell
85:71-81[Medline].
|
| 27a.
| Osborne, R. S., and T. J. Silhavy.
Unpublished data.
|
| 28.
|
Osborne, R. S., and T. J. Silhavy.
1993.
PrlA suppressor mutations cluster in regions corresponding to three distinct topological domains.
EMBO J.
12:3391-3398[Medline].
|
| 29.
|
Pakula, A. A., and M. I. Simon.
1992.
Determination of transmembrane protein structure by disulfide cross-linking: the Escherichia coli Tar receptor.
Proc. Natl. Acad. Sci. USA
89:4144-4148[Abstract/Free Full Text].
|
| 30.
|
Phillips, G. J., and T. J. Silhavy.
1992.
The E. coli ffh gene is necessary for viability and efficient protein export.
Nature
359:744-746[Medline].
|
| 31.
|
Pogliano, K. J., and J. Beckwith.
1993.
The cs sec mutants of Escherichia coli reflect the cold sensitivity of protein export itself.
Genetics
133:763-773[Abstract].
|
| 32.
|
Pohlschroder, M.,
C. Murphy, and J. Beckwith.
1996.
In vivo analyses of interactions between SecE and SecY, core components of the Escherichia coli protein translocation machinery.
J. Biol. Chem.
271:19908-19914[Abstract/Free Full Text].
|
| 33.
|
Pohlschroder, M.,
W. A. Prinz,
E. Hartmann, and J. Beckwith.
1997.
Protein translocation in the three domains of life: variations on a theme.
Cell
91:563-566[Medline].
|
| 34.
|
Rapoport, T. A.,
B. Jungnickel, and U. Kutay.
1996.
Protein transport across the eukaryotic endoplasmic reticulum and bacterial inner membranes.
Annu. Rev. Biochem.
65:271-303[Medline].
|
| 35.
|
Roth, B. L.,
M. Poot,
S. T. Yue, and P. J. Millard.
1997.
Bacterial viability and antibiotic susceptibility testing with SYTOX green nucleic acid stain.
Appl. Environ. Microbiol.
63:2421-2431[Abstract].
|
| 36.
|
Silhavy, T. J.,
M. L. Berman, and L. W. Enquist.
1984.
Experiments with gene fusions.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 37.
|
Talmadge, K.,
S. Stahl, and W. Gilbert.
1980.
Bacteria mature preproinsulin to proinsulin.
Proc. Natl. Acad. Sci. USA
77:3369-3373[Abstract/Free Full Text].
|
| 38.
|
Ulbrandt, N. D.,
J. A. Jewitt, and H. D. Bernstein.
1997.
The E. coli signal recognition particle is required for the insertion of a subset of inner membrane proteins.
Cell
88:187-196[Medline].
|
| 39.
|
von Heijne, G.
1985.
Signal sequences: the limits of variation.
J. Mol. Biol.
184:99-105[Medline].
|
| 40.
|
Whitley, P.,
L. Nilsson, and G. von Heijne.
1993.
Three-dimensional model for the membrane domain of Escherichia coli leader peptidase based on disulfide mapping.
Biochemistry
32:8534-8539[Medline].
|
| 41.
|
Wilkinson, B. M.,
Y. Esnault,
R. A. Craven,
F. Skiba,
J. Fieschi,
F. Kepes, and C. J. Stirling.
1997.
Molecular architecture of the ER translocase probed by chemical crosslinking of Sss1p to complementary fragments of Sec61p.
EMBO J.
16:4549-4559[Medline].
|
Journal of Bacteriology, June 1999, p. 3438-3444, Vol. 181, No. 11
0021-9193/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Boy, D., Koch, H.-G.
(2009). Visualization of Distinct Entities of the SecYEG Translocon during Translocation and Integration of Bacterial Proteins. Mol. Biol. Cell
20: 1804-1815
[Abstract]
[Full Text]
-
Gumbart, J., Schulten, K.
(2008). The Roles of Pore Ring and Plug in the SecY Protein-conducting Channel. JGP
132: 709-719
[Abstract]
[Full Text]
-
Erlandson, K. J., Or, E., Osborne, A. R., Rapoport, T. A.
(2008). Analysis of Polypeptide Movement in the SecY Channel during SecA-mediated Protein Translocation. J. Biol. Chem.
283: 15709-15715
[Abstract]
[Full Text]
-
Bol, R., de Wit, J. G., Driessen, A. J. M.
(2007). The Active Protein-conducting Channel of Escherichia coli Contains an Apolar Patch. J. Biol. Chem.
282: 29785-29793
[Abstract]
[Full Text]
-
Maillard, A. P., Lalani, S., Silva, F., Belin, D., Duong, F.
(2007). Deregulation of the SecYEG Translocation Channel upon Removal of the Plug Domain. J. Biol. Chem.
282: 1281-1287
[Abstract]
[Full Text]
-
Barak, Y., Ackerley, D. F., Dodge, C. J., Banwari, L., Alex, C., Francis, A. J., Matin, A.
(2006). Analysis of novel soluble chromate and uranyl reductases and generation of an improved enzyme by directed evolution.. Appl. Environ. Microbiol.
72: 7074-7082
[Abstract]
[Full Text]
-
Junne, T., Schwede, T., Goder, V., Spiess, M.
(2006). The Plug Domain of Yeast Sec61p Is Important for Efficient Protein Translocation, but Is Not Essential for Cell Viability. Mol. Biol. Cell
17: 4063-4068
[Abstract]
[Full Text]
-
Smith, M. A., Clemons, W. M. Jr., DeMars, C. J., Flower, A. M.
(2005). Modeling the Effects of prl Mutations on the Escherichia coli SecY Complex. J. Bacteriol.
187: 6454-6465
[Abstract]
[Full Text]
-
Cannon, K. S., Or, E., Clemons, W. M. Jr., Shibata, Y., Rapoport, T. A.
(2005). Disulfide bridge formation between SecY and a translocating polypeptide localizes the translocation pore to the center of SecY. JCB
169: 219-225
[Abstract]
[Full Text]
-
Veenendaal, A. K. J., van der Does, C., Driessen, A. J. M.
(2002). The Core of the Bacterial Translocase Harbors a Tilted Transmembrane Segment 3 of SecE. J. Biol. Chem.
277: 36640-36645
[Abstract]
[Full Text]
-
Rizzitello, A. E., Harper, J. R., Silhavy, T. J.
(2001). Genetic Evidence for Parallel Pathways of Chaperone Activity in the Periplasm of Escherichia coli. J. Bacteriol.
183: 6794-6800
[Abstract]
[Full Text]
-
Swaving, J., van Wely, K. H. M., Driessen, A. J. M.
(1999). Preprotein Translocation by a Hybrid Translocase Composed of Escherichia coli and Bacillus subtilis Subunits. J. Bacteriol.
181: 7021-7027
[Abstract]
[Full Text]
-
Dapic, V., Oliver, D.
(2000). Distinct Membrane Binding Properties of N- and C-terminal Domains of Escherichia coli SecA ATPase. J. Biol. Chem.
275: 25000-25007
[Abstract]
[Full Text]
-
Veenendaal, A. K. J., van der Does, C., Driessen, A. J. M.
(2001). Mapping the Sites of Interaction between SecY and SecE by Cysteine Scanning Mutagenesis. J. Biol. Chem.
276: 32559-32566
[Abstract]
[Full Text]